Chappon C
Sem Hop. 1978;54(25-28):821-3.
The action of tiapride on headaches has been studied in several neurological departments, both in hospitalized and ambulatory patients. A favourable result was obtained in 63,3% of cases (nearly 2 out of 3). A dosage of 400 mg/day is adequate for an opinion of the efficacy of the product to be made, with the average dosage is about 150 mg/day (1/2 table x 3 times a day). Tolerance is excellent. Side-effects, wich were noted in 18% of the patients, consist mainly of somnolence and more rarely akathisia. The good results obtained, and the excellent tolerance, enable its use in debilitated alcoholics, the elderly, and those with vascular disorders.
在多个神经科部门，针对住院患者和门诊患者，对硫必利治疗头痛的作用进行了研究。63.3%的病例（近三分之二）取得了良好效果。要对该产品的疗效形成判断，400毫克/天的剂量就足够了，平均剂量约为150毫克/天（半片×每日3次）。耐受性极佳。18%的患者出现了副作用，主要为嗜睡，较少见的是静坐不能。所取得的良好效果以及极佳的耐受性，使其可用于体弱的酗酒者、老年人以及患有血管疾病的患者。
